Carcinoid Syndrome

• FDA approval · 2013-05-23
  FDA Approved: OCTREOTIDE ACETATE — Supplemental Application (Mylan Institutional LLC)

  FDA approved a supplemental application for Octreotide acetate submitted by Mylan Institutional LLC.

• FDA approval · 2012-09-12
  FDA Approved: OCTREOTIDE ACETATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

  FDA approves a supplemental application for octreotide acetate (ANDA) by Hikma Pharmaceuticals USA Inc. The approval updates the labeling or…

• FDA approval · 2012-06-28
  FDA Approved: OCTREOTIDE ACETATE — Supplemental Application (Meitheal Pharmaceuticals, Inc.)

  The FDA approved a supplemental application for octreotide acetate from Meitheal Pharmaceuticals, authorizing a generic version of the drug.…

• FDA approval · 2011-02-10
  FDA Approved: OCTREOTIDE ACETATE — Original Application (Mylan Institutional LLC)

  The FDA approved the original ANDA for octreotide acetate from Mylan Institutional LLC. This marks the generic approval for this product.

• FDA approval · 2009-03-03
  FDA Approved: OCTREOTIDE ACETATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

  FDA approved a supplemental application for octreotide acetate submitted by Hikma Pharmaceuticals USA Inc., under the ANDA pathway.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.